Pricing Log in Create free account

Genelux Corporation (GNLX) vs Milestone Pharmaceuticals Inc. (MIST)

Genelux Corporation and Milestone Pharmaceuticals Inc. are both Biotechnology companies. Genelux Corporation and Milestone Pharmaceuticals Inc. are of similar size ($86.2M and $82.4M). Genelux Corporation has the higher net margin (0.00% vs −1,586.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Genelux Corporation leads on 11 and Milestone Pharmaceuticals Inc. on 4.

Valuation

Metric GNLX MIST Biotechnology median
P/E n/m n/m 10.60
P/S 7.88 19.90 9.40
P/B 5.50 5.79 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.08 0.66
EV/Sales 6.97 (1.13) 9.02
Earnings yield (43.65%) (90.79%) (32.88%)
Free cash flow yield (32.38%) (58.48%) (23.13%)

Profitability

Metric GNLX MIST Biotechnology median
Gross margin (3.42%) 13.27% 68.51%
Operating margin 0.00% (1,479.69%) 0.00%
Net margin 0.00% (1,586.01%) 0.00%
Free cash flow margin 0.00% (1,163.79%) 0.00%
Return on equity (177.93%) (35,522.62%) (51.96%)
Return on assets (121.80%) (73.36%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GNLX MIST Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 9.47% (11.94%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GNLX MIST Biotechnology median
Debt to equity 0.00 3.25 0.00
Current ratio 2.39 8.13 4.97
Net debt to EBITDA 0.44 0.79 1.01

Dividend

Metric GNLX MIST Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GNLX MIST Biotechnology median
Market cap 82.35m 86.21m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack